Diagnostic clinical features of pentazocine-induced ulcers

International Journal of Dermatology

Volumn 44, Issue 11, 2005, Pages 910-915

  Prasad, H R Y ^a   Khaitan, Binod K ^a   Ramam, M ^a   Sharma, Vinod K ^a   Pandhi, Ravinder K ^a   Agarwal, Saurabh ^a   Dhawan, Anju ^a   Jain, Raka ^a   Singh, Manoj K ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; DEXTROPROPOXYPHENE; NALTREXONE; PENTAZOCINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; DRUG ABUSE; DRUG INDUCED DISEASE; FEMALE; HUMAN; HUMAN TISSUE; HYPERPIGMENTATION; INDIA; MALE; MUSCLE CONTRACTURE; PAIN; PERIPHERAL EDEMA; PERIPHERAL VEIN; PSYCHOTHERAPY; PUFFY HAND SYNDROME; SELF MEDICATION; SKIN INDURATION; SKIN ULCER; SYNDROME; URINALYSIS; VASCULAR ACCESS;

ADULT; COHORT STUDIES; COMBINED MODALITY THERAPY; DEBRIDEMENT; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; INDIA; LEG ULCER; MALE; PENTAZOCINE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SKIN TRANSPLANTATION; SKIN ULCER;

EID: 28444473533     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2004.02291.x     Document Type: Article

References (18)

1. Council on Drugs; American Medical Association. The misuse of pentazocine: its dependence producing potential. J Am Med Assoc 1969; 209: 1518-1519.
2. Inciardi JA, Chambers CD. Patterns of pentazocine abuse and addiction. N Y State J Med 1971; 71: 1727-1733.
3. Swanson DW, Weddige RL, Morse RM. Hospitalized pentazocine abusers. Mayo Clin Proc 1973; 48: 85-93.
4. Schlicher JE, Zuehlke RL, Lynch PJ. Local changes at site of pentazocine injection. Arch Dermatol 1971; 104: 90-91.
5. Parks DL, Perry HO, Muller SA. Cutaneous complications of pentazocine injections. Arch Dermatol 1971; 104: 231-235.
6. Schiff BL, Kern AB. Unusual cutaneous manifestations of pentazocine addiction. J Am Med Assoc 1977; 238: 1542-1543.
7. Palestine RF, Millns JL, Spigel GT, et al. Skin manifestations of pentazocine abuse. J Am Acad Dermatol 1980; 2: 47-55.
8. Mann RJ, Gostelow BE, Meacock DJ, et al. Pentazocine ulcers. J R Soc Med 1982; 75: 903-905.
9. Neviaser RJ, Butterfield W, Wieche DR. The puffy hand of drug addiction: a study of pathogenesis. J Bone Joint Surg Am 1971; 54: 629-633.
10. Joong S, Rollins JL, Lewis I. Pentazocine induced fibrous myopathy. J Am Med Assoc 1975; 231: 271-273.
11. Johnson KR, Hsueh WA, Glusman SM, et al. Fibrous myopathy. A rheumatic complication of drug abuse. Arthritis Rheum 1976; 19: 923-926.
12. Jain A, Bhattacharya SN, Singal A, et al. Pentazocine induced widespread cutaneous and myo-fibrosis. J Dermatol 1999; 26: 368-370.
13. Kim HA, Song YW. Polymyositis developing after prolonged injections of pentazocine. J Rheumatol 1996; 23: 1644-1646.
14. Girolami A, Cella G. Acute superficial phlebitis in a patient with hemophilia A: probably a iatrogenic effect. Acta Haemat 1972; 48: 307-311.
15. Jain R. Analytical methods. In: Jain R, ed. Detection of Drugs of Abuse in Body Fluids. A Manual for Laboratory Personnel. New Delhi: Drug Dependence Treatment Centre AIIMS, 1998; 18-44.
16. Padilla RS, Becker LE, Hoffman H, et al. Cutaneous and venous complications of pentazocine abuse. Arch Dermatol 1979; 115: 975-977.
17. Vereby K. Diagnostic laboratory: screening for drug abuse. In: Lowinson JH, Ruiz P, Millman RB, eds. Substance Abuse. A Comprehensive Textbook. Baltimore: Williams and Wilkins, 1992; 425-436.
18. Cosman B, Feliciano WC, Wolff M. Pentazocine ulcers. Plast Reconstr Surg 1977; 59: 255-259.